Elmer, good to see somebody else spotting the value in this share. Given they are backed by big pharma and have shown very encouraging data on their lead candidates I'm surprised with the valuation. This seems to be a great buying opportunity given Baxter invested a year ago at 93c and a number of candidates have progressed since